DOSSIER · 13F-HR · Q2 2026

Regal Partners Ltd

$1.8B in tracked AUM across 174 positions as of Q2 2026.

RP
CIK 0001577774 · last filed Jun 30, 2026
Total AUM
$1.8B
as of Q2 2026
Holdings
174
positions
Whale Score
69
69
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of Regal Partners Ltd SEC 13F Filing
1. Portfolio Overview

Regal Partners Ltd reported a significant contraction in portfolio value for the quarter ended September 30, 2025. The total portfolio value decreased by 49.0%, dropping from $1.18 billion to $603.34 million. This reduction is not solely attributable to market performance but reflects a substantial capital reallocation strategy, evidenced by the high volume of portfolio turnover. The manager curr...

2. Key Holdings

The portfolio is dominated by a few high-conviction positions in the Basic Materials, Financial Services, and Healthcare sectors.

  • Freeport-McMoRan Inc (FCX): Remains the largest holding, valued at $95.34 million, representing 15.80% of the portfolio. Despite a reduction of 2.43 million shares (-15.2%), FCX retains its position as the primary anchor, indicating a continued bullish stance on copper and gold.
  • Apollo Global Management Inc (APO): The second-largest holding at $84.58 million (14.02%). The firm increased this stake by 32.3%, adding $16.54 million, signaling strong confidence in alternative asset management.
  • Sanofi SA (SNY): A major healthcare position valued at $78.24 million (12.97%). This position was increased by 7.1%, suggesting a defensive value play in the pharmaceutical sector.
  • Alphabet Inc (GOOG): The top technology holding, valued at $52.19 million (8.65%).
  • Royalty Pharma PLC: Represents 8.39% of the portfolio ($50.63M), further diversifying the healthcare exposure through a royalty model.
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
NEM
Newmont Corp
$181M1.9M10.0%
02
APO
Apollo Global Management Inc
$166M1.4M9.2%
03
BAC
Bank of America Corp
$150M2.6M8.3%
04
G7709Q104
Royalty Pharma PLC
$137M2.4M7.6%
05
SCHW
Charles Schwab Corp/The
$122M1.3M6.7%
06
SNY
Sanofi SA
$113M2.7M6.3%
07
FCX
Freeport-McMoRan Inc
$109M1.7M6.0%
08
TECK
Teck Resources Ltd
$101M1.7M5.6%
09
WYNN
Wynn Resorts Ltd
$87M898K4.8%
10
DIS
Walt Disney Co/The
$76M790K4.2%

Filing history

2026Q2Jun 30
$1.8B 1.5%
174 positionsView →
2026Q1Mar 31
$1.8B 6.1%
159 positionsView →
2025Q4Dec 31
$1.7B 187.5%
154 positionsView →
2025Q3Sep 30
$603M 49.0%
78 positionsView →
2025Q2Jun 30
$1.2B 21.2%
106 positionsLocked
2025Q1Mar 31
$976M 1.1%
81 positionsLocked
2024Q4Dec 31
$988M 12.7%
97 positionsLocked
2024Q3Sep 30
$1.1B 17.2%
87 positionsLocked
2024Q2Jun 30
$965M 3.0%
79 positionsLocked
2024Q1Mar 31
$995M 5.8%
53 positionsLocked
2023Q4Dec 31
$940M 109.9%
45 positionsLocked
2023Q3Sep 30
$448M 3.1%
41 positionsLocked
Showing 12 of 52